Emulate

OverviewSuggest Edit

Emulate is a company focused on commercializing Organs-on-Chips. Its Human Emulation System is a new living system that emulates human biology for understanding how different diseases, medicines, chemicals and foods affect human health. 

TypePrivate
Founded2013
HQBoston, MA, US
Websiteemulatebio.com
Employee Ratings3.3
Overall CultureC-

Latest Updates

Employees (est.) (Sept 2021)103
Cybersecurity ratingCMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Emulate

Jim Corbett

Jim Corbett

CEO and Board Member
Lorna Ewart

Lorna Ewart

EVP, Science
Larry Weiss

Larry Weiss

Chief Legal Officer, SVP
Stuart Gibb

Stuart Gibb

VP, Sales
Donald Ingber

Donald Ingber

Scientific Founder
Martin Madaus

Martin Madaus

Executive Chairman
Show more

Emulate Office Locations

Emulate has an office in Boston
Boston, MA, US (HQ)
27 Drydock Ave
Show all (1)

Emulate Financials and Metrics

Summary Metrics

Founding Date

2013

Emulate total Funding

$95 m

Emulate latest funding size

$36 m

Time since last funding

3 years ago

Emulate investors

Emulate's latest funding round in June 2018 was reported to be $36 m. In total, Emulate has raised $95 m
Show all financial metrics

Emulate Cybersecurity Score

Cybersecurity ratingPremium dataset

C

79/100

SecurityScorecard logo

Emulate Online and Social Media Presence

Embed Graph

Emulate Company Culture

  • Overall Culture

    C-

    68/100

  • CEO Rating

    F

    40/100

  • Compensation

    D-

    50/100

Learn more on Comparably

Emulate News and Updates

Emulate Inc closes $82M Series E to fund expansion of “organ-on-a-chip” products

Emulate Inc., a biotech company focused on developing “organ-on-a-chip” technology, closed an $82 million Series E round on Tuesday. This latest round is intended to formulate a massive investment in a “roadmap” for developing model organ systems created to fit drugmakers’ needs and bring the idea o…

16 Habits Of The Wealthy Anyone Would Be Wise To Emulate

The very wealthy do have access to some resources that others don’t, but many have also acquired smart habits that help them guard and build their fortunes.

Emulate Names Donald Ingber to Board of Directors

BOSTON, Feb. 18, 2021 /PRNewswire/ -- Emulate, Inc., a leading provider of organ-on-a-chip technology today announced the appointment of Donald Ingber, M.D., Ph.D., to its Board of Directors. Ingber, the scientific founder of Emulate and Chairman of its Scientific Advisory Board is a...

Emulate Announces Organ-on-a-Chip Application and Services Roadmap

BOSTON, Jan. 8, 2021 /PRNewswire/ -- Emulate, Inc., a leading provider of advanced in vitro models, today announced an application roadmap for their market leading organ-on-a-chip technology that expands beyond small molecule applications and addresses the growing focus on targeted and...

Banks Emerge As The Digital-First Leaders Other Industries Will Emulate

To combat rising fraud rates, banks have emerged as leaders in the adoption of real-time risk analytics powered by machine learning.
Show more

Emulate Blogs

Customer Spotlight: Queen Mary University London’s Centre for Predictive in vitro Models

For academic researchers, keeping up with innovative approaches to solving problems can be a never-ending exercise as new technologies displace older methods of experimentation. At Queen Mary University London (QMUL), […] The post Customer Spotlight: Queen Mary University London’s Centre for Predict…

Emulate Endorses the FDA Modernization Act of 2021

In April 2021, a bipartisan congressional committee took a big step towards modernizing the way therapeutics are developed in the United States by proposing the FDA Modernization Act of 2021—an […] The post Emulate Endorses the FDA Modernization Act of 2021 appeared first on Emulate.

Charting Our Path Forward: Determination and Resilience Attracts $82M Series E Funding

CEO, Jim Corbett, shares how new funding will enable Emulate to expand research and development efforts to new heights In March 2020, I was fortunate to join Emulate, intrigued by one of those rare […] The post Charting Our Path Forward: Determination and Resilience Attracts $82M Series E Funding ap…

Creating an Effective Pre-Clinical Model of Bone Marrow

A summary of the paper published in Nature Biomedical Engineering: On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology. Human bone marrow is the body’s major site of hematopoiesis, […] The post Creating an Effective Pre-Clinical Model of Bone Marrow appeare…

Modeling a Better Human Immune Response to Vaccination Using Lymphoid Follicle Organ-Chips

Testing new vaccines against seasonally emerging influenza strains is a necessary process, due to frequent changes in the virus’s immunogenic surface proteins. Vaccines and other drugs, such as immunotherapies, are evaluated […] The post Modeling a Better Human Immune Response to Vaccination Using L…

Using Organs-On-Chips to Evaluate On-Target/Off-Tumor Effects of Cancer Immunotherapies

  Cancer immunotherapy approaches are having their moment in the clinical spotlight. Over two decades of work characterizing potent activators of the immune system have delivered impressive results with biologic […] The post Using Organs-On-Chips to Evaluate On-Target/Off-Tumor Effects of Cancer Imm…
Show more

Emulate Frequently Asked Questions

  • When was Emulate founded?

    Emulate was founded in 2013.

  • Who are Emulate key executives?

    Emulate's key executives are Jim Corbett, Lorna Ewart and Larry Weiss.

  • How many employees does Emulate have?

    Emulate has 103 employees.

  • Who are Emulate competitors?

    Competitors of Emulate include Bionit Labs, Cardiac Dimensions and RTI Surgical.

  • Where is Emulate headquarters?

    Emulate headquarters is located at 27 Drydock Ave, Boston.

  • Where are Emulate offices?

    Emulate has an office in Boston.

  • How many offices does Emulate have?

    Emulate has 1 office.